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Consolidated Medication Review Algorithm to Improve Medications Use in Older Adults: 
Components, Scoring Scheme and Implementation 
 
To the Editor: 
Medication review algorithms and minimisation frameworks are known to aid reviewers in 
identifying and discontinuing potentially inappropriate medications, which may otherwise lead 
older population to harmful events.
1
 There have been many algorithms and minimisation 
frameworks that have been developed to aid to evaluate medication reviews, with each one 
offering benefits in various settings. In 2007, Pollock et al. proposed an eight-step approach to 
improve prescribing by family physicians.
2
 Scott et al. (2012) further developed the concept 
proposed by Pollock et al. (2007) to a ten-step framework that aimed to improve medicines use 
and to reduce the number of inappropriate medications prescribed to older people.
3
 Poudel et al. 
(2015) further condensed the ten-step framework to a four-step algorithm that guides clinicians 
in reviewing the medications, but it is targeted at frail older patients living in aged care 
facilities.
1
 Many other independent models and algorithms have also been designed.
4-6
 A 
commonality that exists among all medication review algorithms and minimisation frameworks 
is that all of them lack scoring scheme to quantify medication review process. In this context, a 
new consolidated medication review algorithm is being developed. 
 
Consolidated Medication Review Algorithm 
Our algorithm is different from the previous algorithms in two ways, first it incorporates the 
potentially inappropriate medication (PIM) component, second it includes a scoring scheme 
which correspond to the components in the algorithm (Figure 1). The scores derived from the 
algorithm will allow for an effective periodical review to observe improvements in medicine use.  
 
Components of an algorithm  
The components in our version of medication review algorithm are: ascertain and validate 
indications of the medications (consult prescriber and credible resources like Micromedex®); 
identify therapeutic duplications (review complete list of current medications); ascertain the 
effectiveness of the medications (cross-referenced via objective measurements as per patient 
records, or obtained via clarification with the respective prescriber); perform a two-stage 
screening of the medications; 4a. Identify potentially inappropriate medications (consider Tables 
2 and 3 of 2015 Beers Criteria,
7
 and/ or START/STOPP criteria
8
); 4b. Identify medications to be 
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used with caution (consider Table 4 of 2015 Beers Criteria
7
), appropriateness of the dosing 
regimen (consider Table 5 of 2015 Beers Criteria,
7
 or credible resources, e.g. Micromedex®, and 
consult prescriber),  contraindications (consider resources e.g. Micromedex®), incidence of 
adverse drug events (consider Table 6 on drug interactions from 2015 Beers Criteria;
7
 ADRs 
consider Naranjo adverse drug reaction probability scale
9
), consider continuing, discontinuing or 
substituting medications (consult prescriber). If the medicine is deemed ineffective for the 
patient, then the medication is warranted for discontinuation, in which the withdrawal regimen 
(consider Table developed by Poudel et al.
1
) or non-pharmacological interventions should be 
considered.  
 
Scoring scheme 
The scores are generated in a similar manner like Medication Appropriateness Index (MAI).
10
 
According to scoring scheme, appropriate items are scored 0 and inappropriate responses are 
scored 1. The weighting scheme combines all the criteria, and they are as follows: 3 for 
indication, effectiveness, use of PIM and drug-disease interactions; 2 for dosage, directions and 
drug-drug interactions; and 1 for duplication, duration and expense. A higher single score means 
increased medication inappropriateness (possible score range of 0-21). A medication is deemed 
inappropriate overall and should be discontinued if the medication scored a rating of 3 or above. 
The ADR component was excluded from the scoring scheme, mainly due to uncertainty of 
causality. It may not be feasible to determine the cause of an ADR instantaneously and would 
require further clarification.  
 
Implementation  
We implemented this algorithm in a 6-month prospective study among 202 residents aged 65 
years and above across 17 aged care facilities in Malaysia (Ethics approval was obtained – 
Project IDIA422, Research Code, XX University, Kuala Lumpur, Malaysia 349/2016). The 
proportions of older adults exposed to inappropriate medications detected by our scoring scheme 
that were not detected by the MAI were 39.7% at baseline, 34.8% at 3-months and 34.3% at 6-
months. Conversely the proportion of older adults exposed to inappropriate medications detected 
by the MAI that were not detected by our scoring scheme were almost none or close to minimal 
(0.0% at baseline and at 6-months, and 3.5% at 3-months). It is also noteworthy that the 
incorporation of the PIMs is crucial in a medication review algorithm for the older people as 
  
there are many benefits when PIMs are avoided in this population. The medication review should 
be objective in nature, also a review with stepwise approach would allow easy implementation. 
 
References 
1. Poudel A, Ballokova A, Hubbard RE, Gray LC, Mitchell CA, Nissen LM, et al. 
Algorithm of medication review in frail older people: Focus on minimizing the use of 
high-risk medications. Geriatr Gerontol Int 2015 Sep 3; 16(9): 1002–13.  
2. Pollock M, Bazaldua OV, Dobbie AE. Appropriate prescribing of medications: an eight-
step approach. Am Fam Physician 2007 Jan 15; 75(2): 231–6.  
3. Scott IA, Gray LC, Martin JH, Mitchell CA. Minimizing inappropriate medications in 
older populations: a 10-step conceptual framework. Am J Med 2012 Jun; 125(6): 529–
37.e4.  
4. Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication 
appropriateness for patients late in life. Arch Intern Med 2006 Mar 27; 166(6): 605–9, 
5. Jetha S. Polypharmacy, the Elderly, and Deprescribing. Consult Pharm J Am Soc Consult 
Pharm 2015 Sep; 30(9): 527–32. 
6. Hilmer SN, Gnjidic D, Le Couteur DG. Thinking through the medication list - 
appropriate prescribing and deprescribing in robust and frail older patients. Aust Fam 
Physician 2012 Dec; 41(12): 924–8. 
7. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American 
Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication 
Use in Older Adults. J Am Geriatr Soc 2015 Nov; 63(11): 2227–46.  
8. O’Mahony D, Gallagher P, Ryan C, Byrne S, Hamilton H, Barry P, et al. STOPP & 
START criteria: A new approach to detecting potentially inappropriate prescribing in old 
age. Eur Geriatr Med 2010 Feb; 1(1): 45–51. 
9. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for 
estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981 Aug; 
30(2): 239–45.  
10. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A 
method for assessing drug therapy appropriateness. J Clin Epidemiol 1992 Oct; 45(10): 
1045–51.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
NO 
CONSIDER 
STOPPING 
YES 
PERFORM A TWO-STAGE SCREENING:  
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WITH CAUTION, CONTRAINDICATIONS, 
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REGIMEN** (TABLES 3-6 & Other Credible 
Resources)
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*ADE COMPRISES DRUG INTERACTIONS & ADVERSE DRUG REACTIONS 
SCREEN ALL MEDICATIONS 
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